The company that made billions selling OxyContin has filed for bankruptcy protection. This comes after it reached a tentative settlement with many of the more than 2,000 governments that are suing it over its role in the opioid crisis. (Sept. 16)
This website uses cookies. By continuing to use this site, you accept our use of cookies.